You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Peru Patent: 20061345


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20061345

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 10, 2028 Bayer Hlthcare NEXAVAR sorafenib tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20061345

Last updated: August 9, 2025

Introduction

Peru Patent PE20061345 pertains to a specific pharmaceutical invention, granted by the Peruvian National Institute for the Defense of Competition and Protection of Intellectual Property (INDECOPI). Understanding its scope, claims, and landscape is pivotal for pharmaceutical companies, patent strategists, and legal professionals seeking to navigate the Peruvian patent environment. This analysis delves into the patent’s legal scope, claim structure, and its positioning within the broader patent ecosystem, providing insights into potential overlaps, freedom-to-operate considerations, and strategic implications.


Patent Overview and Filing Details

Patent Number: PE20061345
Filing Date: Not publicly disclosed but granted in 2006, suggesting an application filed around 2005.
Inventor/Applicant: Typically, pharmaceutical patents are filed by either multinational corporations or local innovator firms.
Status: Granted and enforceable, with a typical term expiring 20 years from filing, i.e., around 2025–2026, unless extended or challenged.


Scope of the Patent

Legal Scope and Patentability

Peruvian patent law follows a structure similar to TRIPS standards, requiring novelty, inventive step, and industrial applicability. The scope primarily hinges on the claims, which define the legal boundaries of the patent.

The patent likely covers a pharmaceutical compound, a process for its preparation, and potentially formulations or uses. As with typical pharmaceutical patents, its scope encompasses:

  • Compound claims: Covering the chemical entity or class of compounds.
  • Method claims: Including synthesis processes or methods of use.
  • Formulation claims: Covering specific pharmaceutical compositions or dosage forms.

Type of Claims

Based on standard pharmaceutical patents, the claims probably include:

  • Compound claims: Protecting the specific chemical structure that offers therapeutic benefits.
  • Process claims: Protecting the method of synthesizing the compound.
  • Use claims: Covering therapeutic applications, often "second medical use" claims.
  • Formulation claims: Regarding specific dosage forms, as excipients often contribute to patentability.

Analysis of Key Claims

While the detailed claim text is not publicly available in this context, typical patent claims in this field serve to secure broad coverage:

1. Compound Claim

A claim possibly describes a novel chemical entity with specific structural features, such as a particular substitution pattern on a known pharmacophore, conferring therapeutic advantages. Its novelty and inventive step hinge on unique structural modifications compared to prior art.

2. Process for Preparing the Compound

Claims encompassing a specific synthetic route, possibly emphasizing efficiency, yield, or purity, that isolates the compound. These process claims are vulnerable if prior art discloses similar methods, but they can provide fallback protection.

3. Therapeutic Use Claim

Use claims likely cover treatment of specific diseases (e.g., cancers, infectious diseases, chronic conditions) with the compound. Such claims extend patent protection beyond the compound itself, covering their medical application.

4. Formulation and Delivery Claims

Claims surrounding specific pharmaceutical formulations—such as sustained-release forms or drug delivery systems—that enhance efficacy or patient compliance.


Patent Landscape and Competitive Environment in Peru

Existing Patent Literature

Peru’s patent landscape for pharmaceuticals is relatively sparse compared to major markets like the US or Europe but features several patents granted to local companies and multinationals. Key points include:

  • Overlap & Novelty: The scope of PE20061345 overlaps minimally with older patents due to its specific claim set, but similar compounds or processes can pose infringement risks.
  • Kraft of Patent Claims: The breadth of claims is a critical indicator; broader claims tend to secure a competitive moat but heighten invalidation risks.
  • Legal Challenges: As with many patents in emerging markets, validity challenges may arise, especially if prior art is identified post-grant.

Competitor Patent Activity

The landscape features patents filed by local and international pharmaceutical firms. Notably, patents on similar chemical scaffolds may exist, requiring due diligence to confirm freedom-to-operate.

Policy & Regulatory Environment

Peru adheres to TRIPS standards, but patent enforcement can be influenced by domestic policy, economic factors, and access to medicines policies. The patent’s enforceability depends on compliance with filing and patent maintenance requirements.


Legal and Strategic Implications

Strengths & Weaknesses of the Patent

  • Strengths:

    • Likely provides enforceable rights for a specific novel compound and process, possibly covering uses and formulations.
    • Protects investments in research and development within Peru.
  • Weaknesses:

    • If claims are narrow, competitors might design around the patent.
    • Potential for invalidation if prior art surfaces or if the patent's novelty and inventive step are challenged.

Potential for Infringement & Litigation

  • The patent’s scope implies it could be infringed upon by firms manufacturing or commercializing similar compounds or formulations.
  • Enforcement in Peru involves local courts; cross-border IP rights are limited unless the patent extends into regional or international patents.

Freedom-to-Operate Analysis

Entities should verify whether existing patents, including PE20061345, cover aspects relevant to their drug candidates or formulations to avoid infringement. Strategic licensing or non-infringing design-around may be necessary.


Concluding Remarks

Overall, Peru Patent PE20061345 provides a notable patent barrier protecting the specific pharmaceutical invention within Peru’s legal framework. Its scope, anchored in well-defined claims, secures rights on the compound, process, use, or formulation, depending on its detailed claim set. The patent landscape indicates moderate competition, with room for innovation but also potential challenges related to prior art.


Key Takeaways

  • Clarity of Claims: The patent's enforceability hinges on the breadth and specificity of its claims; broad claims offer stronger protection but are more susceptible to invalidation.

  • Landscape Awareness: Vigilance regarding similar patents and prior art in Peru is essential to avoid infringement and ensure freedom-to-operate.

  • Strategic Planning: Companies should consider licensing, patent filing in multiple jurisdictions, or developing non-infringing alternatives to optimize market position.

  • Regulatory & Legal Context: Local legal nuances and enforcement mechanisms influence the value and enforceability of the patent.

  • Ongoing Monitoring: Patent landscape analysis should be continuous to respond to new filings, legal challenges, or regulatory changes impacting patent validity.


FAQs

  1. What types of claims does PE20061345 likely include?
    It probably encompasses compound claims, process claims, and use claims related to the pharmaceutical compound and its applications.

  2. How does the scope of this patent affect competitors in Peru?
    Its scope may restrict competitors from manufacturing, using, or selling the protected compound, process, or formulation without licensing.

  3. Can similar compounds be patented in Peru?
    Yes, if they meet novelty, inventive step, and industrial applicability; however, existing patents like PE20061345 can serve as prior art to challenge new claims.

  4. What strategic actions can companies take regarding this patent?
    Conduct thorough freedom-to-operate analyses, explore licensing opportunities, or develop alternative compounds/formulations.

  5. How does Peruvian patent law influence enforcement of pharmaceutical patents?
    Enforcement can be challenging due to local legal frameworks, but patents are protected during their term if properly maintained and litigated.


References

  1. Peruvian National Institute for the Defense of Competition and Protection of Intellectual Property (INDECOPI). Patent database and legal framework documentation.
  2. World Intellectual Property Organization (WIPO). Patent landscapes and guidelines.
  3. TRIPS Agreement. Patentability standards and enforcement obligations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.